Mikhail N Ryazantsev

Prof. Mikhail N Ryazantsev

Chemistry, Saint Petersburg State University, Saint Petersburg, Sankt-Peterburg, Russia
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2011 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
ISIgor Schapiro
Igor Schapiro
Mikhail N RyazantsevMikhail N Ryazantsev
Mikhail N Ryazantsev
LFLuis Manuel Frutos
Luis Manuel Frutos
NFNicolas Ferré
Nicolas Ferré
RLRoland Lindh
Roland Lindh
MOMassimo Olivucci
Massimo Olivucci

22 March 2021 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Closed access
DSDaniil Stupin
Daniil Stupin
EKEkaterina A. Kuzina
Ekaterina A. Kuzina
AAAnna A. Abelit
Anna A. Abelit
AEAnton K. Emelyanov
Anton K. Emelyanov
DNDmitrii M. Nikolaev
Dmitrii M. Nikolaev
MDMichael V. Dubina
Michael V. Dubina

18 November 2008 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
Adalgisa SinicropiAdalgisa Sinicropi
Adalgisa Sinicropi
EMElena Martin
Elena Martin
Mikhail N RyazantsevMikhail N Ryazantsev
Mikhail N Ryazantsev
JHJan Helbing
Jan Helbing
JBJulien Briand
Julien Briand
MOMassimo Olivucci
Massimo Olivucci
Single molecules that act as light-energy transducers (e.g., converting the energy of a photon into atomic-level mechanical motion) are examples of minimal molecular devices. Here, we focus on a molecular switch designed by merging a conformationally locked diarylidene skeleton with a retinal-like Schiff base and capable of mimicking, in solution, different aspects of the transduction of the visual pigment Rhodopsin. Complementary ab initio multiconfigurational quantum chemistry-based computations and time-resolved spectroscopy are used to follow the light-induced isomerization of the switch in methanol. The results show that, similar to rhodopsin, the isomerization occurs on a 0.3-ps time scale and is followed by <10-ps cooling and solvation. The entire (2-photon-powered) switch cycle was traced by following the evolution of its infrared spectrum. These measurements indicate that a full cycle can be completed within 20 ps.

22 June 2010 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
AMAlfonso Melloni
Alfonso Melloni
RPRiccardo Rossi Paccani
Riccardo Rossi Paccani
DDDonato Donati
Donato Donati
VZVinicio Zanirato
Vinicio Zanirato
Adalgisa SinicropiAdalgisa Sinicropi
Adalgisa Sinicropi
MOMassimo Olivucci
Massimo Olivucci

9 July 2018 in ACS Omega
Verified
Journal Article
Open access
DNDmitrii M. Nikolaev
Dmitrii M. Nikolaev
ASAndrey A. Shtyrov
Andrey A. Shtyrov
MPMaxim S. Panov
Maxim S. Panov
AJAdeel Jamal
Adeel Jamal
OCOleg B. Chakchir
Oleg B. Chakchir
Mikhail N RyazantsevMikhail N Ryazantsev
Mikhail N Ryazantsev
Rhodopsins are seven α-helical membrane proteins that are of great importance in chemistry, biology, and modern biotechnology. Any in silico study on rhodopsin properties and functioning requires a high-quality three-dimensional structure. Due to particular difficulties with obtaining membrane protein structures from the experiment, in silico prediction of the three-dimensional rhodopsin structure based only on its primary sequence is an especially important task. For the last few years, significant progress was made in the field of protein structure prediction, especially for methods based on comparative modeling. However, the majority of this progress was made for soluble proteins and further investigations are needed to achieve similar progress for membrane proteins. In this paper, we evaluate the performance of modern protein structure prediction methodologies (implemented in the Medeller, I-TASSER, and Rosetta packages) for their ability to predict rhodopsin structures. Three widely used methodologies were considered: two general methodologies that are commonly applied to soluble proteins and a methodology that uses constraints that are specific for membrane proteins. The test pool consisted of 36 target-template pairs with different sequence similarities that was constructed on the basis of 24 experimental rhodopsin structures taken from the RCSB database. As a result, we showed that all three considered methodologies allow obtaining rhodopsin structures with the quality that is close to the crystallographic one (root mean square deviation (RMSD) of the predicted structure from the corresponding X-ray structure up to 1.5 Å) if the target-template sequence identity is higher than 40%. Moreover, all considered methodologies provided structures of average quality (RMSD < 4.0 Å) if the target-template sequence identity is higher than 20%. Such structures can be subsequently used for further investigation of molecular mechanisms of protein functioning and for the development of modern protein-based biotechnologies.

1 November 2017 in Organic Chemistry Frontiers
Verified
Journal Article
Closed access
PDF file
AFA. S. Filatov
A. S. Filatov
NKNickolay A. Knyazev
Nickolay A. Knyazev
Mikhail N RyazantsevMikhail N Ryazantsev
Mikhail N Ryazantsev
VSV. V. Suslonov
V. V. Suslonov
ALA. G. Larina
A. G. Larina
ASA. V. Stepakov
A. V. Stepakov
A simple and efficient method has been developed for the synthesis of complex compounds with spiro-fused 11H-indeno[1,2-b]quinoxaline and cyclopropa[a]pyrrolizine or azabicyclo[3.1.0]hexane moieties. All the products have been synthesized in good to high yields and excellent diastereoselectivity by one-pot three-component 1,3-dipolar cycloaddition reactions of various derivatives of cyclopropene with azomethine ylides. Azomethine ylides were in situ generated from 11H-indeno[1,2-b]quinoxalin-11-one derivatives and amines, such as N-substituted and N-unsubstituted α-amino acids, benzylamines, and also peptides (dipeptide Gly-Gly and tripeptide Gly-Gly-Gly). To understand the mechanism that allows for azomethine ylide generation followed by 1,3-dipolar cycloaddition, a quantum chemical investigation was performed. The anticancer activity of some of the obtained compounds against the human leukemia K562 cell line was evaluated by flow cytometry in vitro.